Reports

After years of debate, research assessment reform has become an urgent priority for policy makers and science organisations alike, both in Europe and beyond. But what are the most effective ways forward? How can all key stakeholders contribute to shaping a new system?

Sponsored by Elsevier.

Innovative collection and use of health data will play a vital role in Europe’s future approach to medicines evaluation and regulation. This report explores what the EU can learn from Denmark, one of the world’s leaders in health data systems and strategies.

Sponsored by the Science|Business Future-Proofing Medicines initiative

The invasion of Ukraine has prompted a wave of measures to isolate Russia’s scientific establishment. As geopolitical tensions mount, we must seek global agreement on how researchers can continue to operate, without aiding an aggressor or hampering science.

A Science|Business discussion paper

New research infrastructures (RIs) are needed in Europe to maintain and propel its leadership in science and technology for decades to come. But how can new RIs attract adequate investment? How can their socio-economic and scientific impacts best be assessed?

Sponsored by Elsevier.

A Science|Business report on what researchers think of Horizon Europe

A discussion paper for the 8-9 February 2022 annual conference of the Science|Business Network and its Technology Strategy Board

With Horizon Europe now under way, public research funders can focus on how to assess the value of scientific research.

Sponsored by Elsevier.

The final conference report sponsored by the CAROTS Project

Europe’s biggest-ever R&D programme is getting under way at last. Science|Business provides an expert – but easy to follow – guide for applicants

New! Updated Autumn 2021!

To curb climate change, European policymakers need access to the best and most up-to-date scientific information and data. How can the research community ensure that happens?